Prostate Cancer

 

Tips&Tools



ProstateCancerNews

www.medpagetoday.com - 10/1/12
VIENNA (MedPage Today) -- An investigational androgen receptor antagonist achieved partial response or stable disease after 12 weeks of therapy in almost all evaluable patients with castration-resistant prostate cancer, an initial clinical study showed.
www.medpagetoday.com - 9/26/12
(MedPage Today) -- A suite of 12 genetic variations may help doctors determine who will have erectile dysfunction after radiation therapy for prostate cancer, researchers reported.
www.medpagetoday.com - 9/25/12
(MedPage Today) -- MRI evaluation of clinically low-risk prostate cancer demonstrated high accuracy for predicting disease status in men evaluated for watchful waiting, data from a prospective clinical study showed.
www.medpagetoday.com - 9/16/12
(MedPage Today) -- Final results of a phase III trial confirm that treatment with abiraterone prolongs overall survival in advanced prostate cancer that has progressed after docetaxel therapy.
www.medpagetoday.com - 7/29/12
(MedPage Today) -- Elimination of PSA testing would triple the number of men who have advanced prostate cancer at diagnosis, authors of a retrospective review concluded.

Result Pages: 1 2 3 4 5 6 7 8 9 10 Previous Next


FeaturedArticles

Lower Back Pain in an Elderly Man With a History of Localized Prostate Cancer
A 70-year-old man with a history of localized prostate cancer treated with whole-pelvis radiation therapy with a boost to the prostate, in conjunction with androgen deprivation therapy 7 years prior, presented with lower back pain. A bone scan revealed an area of activity in the sacrum. What is the... More »
New AUA Guidelines for Prostate Cancer Screening
The American Urological Association (AUA) released a new clinical guideline detailing recommendations for the use of prostate cancer screening in average-risk men based upon evidence from a systematic literature review. The guideline, which was announced during the 2013 AUA Annual Meeting,... More »
Radium-223 Gets Early FDA Nod for Bone Mets in Castration-Resistant Prostate Cancer
Radium-223 dichloride (Xofigo) received FDA approval for the treatment of symptomatic metastatic castration-resistant prostate cancer that has metastasized to the bone but no other organs. More »
Secondary Hormone Therapy for Castration-Resistant Prostate Cancer
The majority of patients with systemic prostate cancer treated with androgen deprivation therapy (ADT) will develop castration-resistant prostate cancer (CRPC). More »
Study: Cholesterol Drugs Reduced Risk of Prostate Cancer Death
A cohort-based study found that men with prostate cancer who took cholesterol-lowering statins had a lower risk of dying from their prostate cancer. More »
Showing 1 - 5 of 670 results.
Page of 134

PubMed

pubmed.gov - 2/28/13
pubmed.gov - 2/14/13
pubmed.gov - 2/14/13
pubmed.gov - 2/14/13
pubmed.gov - 1/31/13
More Results

ClinicalTrials

neuro-oncology.oxfordjournals.org - 1/17/13
www.clinicaltrials.gov -
www.clinicaltrials.gov -
www.clinicaltrials.gov -
www.clinicaltrials.gov -
More Results


PracticeGuidelines

www.ahrq.gov - 8/31/10
www.acponline.org -
www.acponline.org -
www.acponline.org -
www.acponline.org -
www.acponline.org -
More Results


FromPhysiciansPractice

Primary Care Can't Thrive Without Nurse Practitioners
Courtney H. Lyder, ND,  May 17, 2013
With a projected shortfall of primary-care physicians, it's time for alternate solutions to patient care. Nurse practitioners are one logical remedy.
VWhat Physicians Can Learn from the Allscripts EHR Lawsuit
Marisa Torrieri,  May 16, 2013
Lawsuit prompts question: What should physicians do to ensure they end up with a great EHR instead of buyer’s remorse?
Eight Ways ICD-9 Will Still Matter to Medical Practices
Brenda Edwards, CPC,  May 15, 2013
What should your medical practice do with your ICD-9-CM book after October 1, 2014? Keep it.
Seven Ways Technology Can Speed Up Patient Collections
Cheyenne Brinson,  May 15, 2013
Failing to adopt widely available billing and collections technology can cost medical practices big. Here's how to do it right.
Four Reasons Private Medical Practice is Becoming Extinct
Carol Stryker,  May 15, 2013
It’s becoming increasingly difficult for private medical practices to thrive. Here’s what’s driving the trend toward consolidation.
 

 


PatientResources

American Cancer Society
Prostate Cancer


National Cancer Institute
General Information About Prostate Cancer


National Comprehensive Cancer Network
Guidelines for Patients - Prostate Cancer